Management of menopausal symptoms in patients with breast cancer: an evidence-based approach
Authors:
- Martha HickeyMHMartha Hickey
- Christobel M SaundersCSChristobel M Saunders
- Bronwyn Ga StuckeyBSBronwyn Ga Stuckey
- 1 September 2005
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 6 (9) , 687-695
Abstract
No abstract availableKeywords
Funding Information
- Novartis
- Merck Sharp and Dohme United Kingdom
- Eli Lilly and Company
- Pfizer
This publication has 66 references indexed in Scilit:
- Serum Sex Steroids in Premenopausal Women and Breast Cancer Risk Within the European Prospective Investigation into Cancer and Nutrition (EPIC)JNCI: Journal of the National Cancer Institute, 2005
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- Breast cancer and hormone-replacement therapy: the Million Women StudyThe Lancet, 2003
- Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancerJournal of Clinical Epidemiology, 2003
- Hormone replacement therapy with tibolone: effects on sexual functioning in postmenopausal womenActa Obstetricia et Gynecologica Scandinavica, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Oral estrogen replacement therapy versus placebo for hot flushes: a systematic reviewClimacteric, 2001
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesThe Lancet, 1996
- The role of oestrogens and progestagens in the epidemiology and prevention of breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988